Current:Home > StocksAlabama Senate committee delays vote on ethics legislation -GrowthInsight
Alabama Senate committee delays vote on ethics legislation
PredictIQ View
Date:2025-04-06 22:15:12
MONTGOMERY, Ala. (AP) — An Alabama Senate committee on Tuesday delayed action on a proposed revamp of the state ethics law after opposition from both the state attorney general and the head of the state ethics commission.
The Senate Judiciary will take up the bill again Wednesday morning. If approved, it would be in line for a possible Senate vote on the final day of the legislative session, which could be as soon as Thursday.
The attorney general’s office and the director of the Alabama Ethics Commission spoke against the bill during a Tuesday public hearing.
Katherine Robertson, chief counsel for the Alabama attorney general, argued that there is overlap in the bill between what is a criminal offense and what is a civil violation. She urged lawmakers to keep working on it.
“There is really no clear line,” Robertson said.
Matt Hart, a former state and federal prosecutor who spearheaded some of the state’s most notable public corruption prosecutions, said the proposal would weaken the state’s ethics law by allowing some actions that are currently prohibited.
“There are many, many things that are crimes in our ethics law right now that simply go away,” Hart told the committee.
Speaking after the meeting, Hart said the bill would weaken or abolish parts of the current law aimed at preventing conflicts of interest or requiring the disclosure of contracts.
The Alabama House of Representatives approved the bill a month ago on a lopsided 79-9 vote, but it has been stalled since in the Alabama Senate.
“The goal behind it is clarity and to end the confusion,” Republican Rep. Matt Simpson, the bill sponsor, told the committee.
The bill would raise the limit of gifts to public officials and employees to $100 per occasion and $500 per year. Current law prohibits public officials and employees from receiving a “thing of value” from a lobbyist or person who employs a lobbyist, but allows exemptions for items of minimal value, now defined as less than $33.
veryGood! (672)
Related
- Appeals court scraps Nasdaq boardroom diversity rules in latest DEI setback
- Empty Grocery Shelves and Rotting, Wasted Vegetables: Two Sides of a Supply Chain Problem
- Electric Vehicle Advocates See Threat to Progress from Keystone XL Pipeline
- What is Juneteenth? Learn the history behind the federal holiday's origin and name
- Have Dry, Sensitive Skin? You Need To Add These Gentle Skincare Products to Your Routine
- Can a president pardon himself?
- A months-long landfill fire in Alabama reveals waste regulation gaps
- Justin Timberlake Declares He's Now Going By Jessica Biel's Boyfriend After Hilarious TikTok Comment
- Why members of two of EPA's influential science advisory committees were let go
- The Smiths Bassist Andy Rourke Dead at 59 After Cancer Battle
Ranking
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- Ignoring Scientists’ Advice, Trump’s EPA Rejects Stricter Air Quality Standard
- How law enforcement is promoting a troubling documentary about 'sextortion'
- Several States Using Little-Known Fund to Jump-Start the Clean Economy
- Meet first time Grammy nominee Charley Crockett
- Never-Used Tax Credit Could Jumpstart U.S. Offshore Wind Energy—if Renewed
- Mass Die-Off of Puffins Raises More Fears About Arctic’s Warming Climate
- With Tax Credit in Doubt, Wind Industry Ponders if It Can Stand on Its Own
Recommendation
In ‘Nickel Boys,’ striving for a new way to see
Neurotech could connect our brains to computers. What could go wrong, right?
What is Babesiosis? A rare tick-borne disease is on the rise in the Northeast
Megan Fox Rocks Sheer Look at Sports Illustrated Event With Machine Gun Kelly
Toyota to invest $922 million to build a new paint facility at its Kentucky complex
Michigan man arrested for planning mass killing at synagogue
You asked: Can we catch a new virus from a pet? A cat-loving researcher has an answer
Sickle cell patient's success with gene editing raises hopes and questions